Alembic Pharmaceuticals completes USFDA’s inspection at Derma Facility

13 Mar 2023 Evaluate

Alembic Pharmaceuticals has successfully completed the United States Food and Drug Administration (USFDA) inspection for its Derma Facility located at Karakhadi without any observations. The inspection was conducted from March 6, 2023 to March 10, 2023.

Alembic Pharmaceuticals, a vertically integrated research and development pharmaceutical company, has been at the forefront of Healthcare since 1907.

Alembic Pharma Share Price

1044.00 -11.00 (-1.04%)
23-Dec-2024 15:13 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1816.65
Dr. Reddys Lab 1341.95
Cipla 1478.40
Lupin 2160.85
Zydus Lifesciences 973.00
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.